MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-20-0001802
Manglam Biotech Private Limited
Manglam Biotech Private Limited - pharma in Palwal, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.01 Cr
▼ 63% YoY
Net loss · FY 2025
₹8.14 Lakh
Net margin -8.1%
EBITDA · FY 2025
₹11.03 Lakh
EBITDA margin 10.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Manglam Biotech Private Limited
Data last updated:
Manglam Biotech Private Limited is a private limited company based in Palwal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119HR2018PTC076958. Its GSTIN is 06AAMCM2381H1ZC (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Shiv Kumar Mangla and Vishal Mangla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor 89/15 Moty Colony, Palwal, Haryana, India – 121102.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.01 Cr, a decline of 63% compared to the previous year. For the same year it recorded a net loss of ₹8.14 Lakh (net margin -8.1%) and EBITDA of ₹11.03 Lakh (EBITDA margin 10.9%). Revenue has declined at a compounded annual rate (CAGR) of 44% over three years.
As per MCA filings, the company has open charges of ₹2 Cr on record.
Manglam Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-20-0001802).
Company details
CIN U33119HR2018PTC076958
Registration Number 076958
Incorporation Date 19 November 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-20-0001802
Key People
Shiv Kumar Mangla Director Vishal Mangla Director Recognitions & Rankings of Manglam Biotech
Contact details
Manglam Biotech Private Limited's registered office is in Palwal, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFirst Floor 89/15 Moty Colony, Palwal, Haryana, India – 121102
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Manglam Biotech Private Limited, buy the company report.
Comprehensive company report
Manglam Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Manglam Biotech Private Limited
FY 2025 filings availableManglam Biotech Private Limited reported revenue of ₹1.01 Cr (down 63% YoY) for FY 2025.
Revenue · FY 2025
₹1.01 Cr ▼ 63%
Net loss · FY 2025
₹8.14 Lakh margin -8.1%
EBITDA · FY 2025
₹11.03 Lakh margin 10.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 63%
3 years · compounded
▼ 44%
EBITDA CAGR growth
1 year
▼ 52%
3 years · compounded
▼ 24%
5 years · compounded
▲ 149%
Revenue has declined at a compounded annual rate (CAGR) of 44% over three years, including a 63% fall in the latest year. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.9% | ||||
| Net Profit Margin | -8.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manglam Biotech Private Limited, buy the company report.
Board of directors of Manglam Biotech Private Limited
Manglam Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiv Kumar Mangla Also directs: Manglam Medikits Private Limited | Director | 19 Nov 2018 | 7 Years 11 Months | Current |
| Vishal Mangla | Director | 31 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Manglam Biotech Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shelton Pharmaceuticals Private Limited | ₹1.01 Cr (FY 2024) | 78.0% | Gurgaon, Haryana, India | |||
| John Biotech Private Limited | ₹1.01 Cr (FY 2025) | -3.0% | Ahmedabad, Gujarat, India | |||
| Manglam Biotech Private Limitedthis company | ₹1.01 Cr (FY 2025) | -₹8.14 Lakh | -8.1% | -63.0% | Palwal, Haryana, India | |
| Bio-Ved Pharmaceuticals Private Limited | ₹1.01 Cr (FY 2024) | -38.0% | Pune, Maharashtra, India | |||
| Rose Pharmaceuticals and Healthcare Private Limited | ₹1.01 Cr (FY 2024) | -1.0% | R S Naidunagar, Karnataka, India |
To see the full peer comparison of Manglam Biotech Private Limited, buy the company report.
Auditor
Manglam Biotech Private Limited is audited by SRGM & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRGM & ASSOCIATES | FY 2023 | 024189N |
Shareholding
The shareholding of Manglam Biotech Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Manglam Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2021 | 100526136 | Others | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Manglam Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manglam Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Manglam Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAMCM2381H1ZC | Haryana | Active | 05 Oct 2020 |
To see the full GST registrations and return filing status of Manglam Biotech Private Limited, buy the company report.
Recent activity
Manglam Biotech Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Bharti Mangla ceased to be Director on 11 Nov 2021.
AGM
Manglam Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Manglam Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100526136 was registered on 04 Dec 2021.
Ceased
Bharti Mangla ceased to be Director.
Ceased
Rishi Mangla ceased to be Director.
Appointed
Vishal Mangla was appointed as Director.
Appointed
Shiv Kumar Mangla was appointed as Director.
Incorporation
19 Nov 2018
Manglam Biotech Private Limited was registered on 19 Nov 2018 with Roc Delhi & aged 7 years 11 months as per MCA records.
Frequently asked questions
Manglam Biotech is an active private limited company based in Palwal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 November 2018 (8+ years old) and is registered under CIN U33119HR2018PTC076958.
Manglam Biotech has 2 current directors:
- Shiv Kumar Mangla - Director
- Vishal Mangla - Director
The latest financial statements of Manglam Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Manglam Biotech is 06AAMCM2381H1ZC, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Manglam Biotech is U33119HR2018PTC076958. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manglam Biotech was incorporated on 19 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Manglam Biotech by revenue are Shelton Pharmaceuticals Private Limited, John Biotech Private Limited, Bio-Ved Pharmaceuticals Private Limited, Rose Pharmaceuticals and Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bharti Mangla ceased to be Director on 11 Nov 2021. Rishi Mangla ceased to be Director on 04 Aug 2020. Vishal Mangla was appointed as Director on 31 Jul 2020. Manglam Biotech has 4 board changes on record in total.
Yes, Manglam Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-20-0001802).
The registered office of Manglam Biotech is at First Floor 8915 Moty Colony, Palwal, Haryana, India – 121102.
Manglam Biotech operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages